Sudden Cardiac Death.
Cambridge Heart's mission is to reduce the impact of sudden cardiac death by providing non-invasive technologies to identify individuals at risk of life-threatening arrhythmias. Our innovative diagnostic test is used to measure Microvolt T-Wave Alternans (MTWA), a subtle beat-to-beat fluctuation in the T-wave segment of the electrocardiogram. Recent clinical studies show that patients with a normal or negative MTWA test are at minimal risk for life-threatening arrhythmias, while those who have an abnormal test are at increased risk for sudden cardiac arrest and may benefit from ICD therapy.
For more information, CLICK HERE to visit Cambridge Heart's website.